Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...

The algorithm allows users to manage their type 1 diabetes without needing to count carbohydrates or providing pre-meal ...

When insulin dosages are calculated using computer algorithms to reach target blood glucose levels, hospitalized patients are less likely to have episodes of low blood sugar and recover sooner from ...

The FDA has cleared a mobile application that will connect with a next-generation multiple daily injection automated insulin ...

Please provide your email address to receive an email when new articles are posted on . Of 20 hospitals providing insulin algorithms, 60% stated which patients should initiate basal or nutritional ...

Bigfoot Biomedical is doing its part to ensure that the possibility of building a smarter diabetes management system is more than just an urban legend. The tech maker has purchased a new algorithm ...

Invictus Therapeutics, a biotechnology company developing next-generation insulin analogs engineered for automated insulin delivery systems, today announced it has received an Industry Discovery and ...

Senseonics shares gain after Eversense 365 became the first one-year implantable CGM integrated with an automated insulin ...

MILPITAS, Calif.--(BUSINESS WIRE)--Bigfoot Biomedical (Bigfoot), a leader in developing intelligent connected injection support systems, today announced the acquisition of a reinforcement learning ...

The Food and Drug Administration has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with Type 1 diabetes. These two devices, along ...

Eli Lilly, one of the Big Three insulin makers that’s had its eyes on diabetes technology for several years, is making moves to launch a new insulin pump and automated insulin delivery (AID) system in ...

CHICAGO — A novel algorithm based on the normal pancreatic response to food could represent an alternative to carbohydrate counting for premeal insulin bolusing in patients with type 1 diabetes.